搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
10 小时
Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate ...
Beam Therapeutics Inc. (NASDAQ:BEAM) revealed new safety and efficacy data from its BEACON Phase 1/2 trial of BEAM-101 in ...
13 小时
ASH24: Darzalex in smoldering myeloma, Merck’s ADC data and Novo’s sickle cell drug
J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH ...
16 小时
Life-changing gene therapy to help local siblings
When you give to Light Up A Lawn, Light Up A Life, you are supporting programs like Nationwide Children's cutting-edge gene ...
9 小时
Editas Medicine reports updated clinical data from RUBY trial of Reni-cel
Editas Medicine (EDIT) will present updated safety and efficacy data in 28 patients living with severe sickle cell disease treated with ...
13 小时
Beam Therapeutics Advances BEAM-101 Therapy for Sickle Cell
The latest announcement is out from Beam Therapeutics ( (BEAM) ).
ENDPOINTS NEWS
23 小时
Beam shares results from seven patients who received gene-edited sickle cell ...
Beam Therapeutics reported promising trial data from seven sickle cell patients treated with their gene-edited therapy, ...
12 小时
Beam Therapeutics Appoints Sravan Emany as New CFO, Shares Up
BEAM appoints Sravan K. Emany as its new chief financial officer, effective Dec. 19. Shares rise on this leadership transition.
cancerhealth
13 小时
Disease-Modifying Therapies Remain Underused in Sickle Cell Disease Despite Safety and Efficacy
Only one quarter of patients living with sickle cell disease are prescribed disease modifying therapies, particularly newer ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈